← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #943 OF 1,000 MOST-CITED

Before use and after interruption

FDA cited this observation 18 times across 18 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods18
BY FISCAL YEAR
FY20179
FY20169

How FDA worded it — real examples

Failure to clean and sanitize food-contact surfaces in wet-processing before use and after any interruption during which they may have been contaminated, to preclude contamination with microorganisms.

King's Oriental Foods · Seattle, Washington · Foods · 2017-09-21

Failure to clean and sanitize food-contact surfaces in wet-processing before use and after any interruption during which they may have been contaminated, to preclude contamination with microorganisms.

Signature Breads, Inc. · Tempe, Arizona · Foods · 2017-08-02

Failure to clean and sanitize food-contact surfaces in wet-processing before use, to preclude contamination with microorganisms.

R&N Inc. · Unity, Maine · Foods · 2017-07-07

Failure to clean and sanitize food-contact surfaces in wet-processing before use and after any interruption during which they may have been contaminated, to preclude contamination with microorganisms.

Natural Food Works Group, LLC · Denver, Colorado · Foods · 2017-06-28

Failure to clean and sanitize food-contact surfaces in wet-processing before use, to preclude contamination with microorganisms.

Ota Tofu LLC · Portland, Oregon · Foods · 2017-04-26

Failure to clean and sanitize food-contact surfaces in wet-processing before use, to preclude contamination with microorganisms.

Four In One, LLC · Chelmsford, Massachusetts · Foods · 2017-04-07

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Food industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →